Congenital intrahepatic portosystemic shunt diagnosed during intrauterine life  by Bellettini, Camila Vieira et al.
RC
C
d
C
A
E
a
b
R
A
h
2
lev Paul Pediatr. 2016;34(3):384--387
REVISTA  PAULISTA
DE PEDIATRIA
www.rpped.com.br
ASE REPORT
ongenital  intrahepatic  portosystemic  shunt  diagnosed
uring intrauterine  life
amila Vieira Bellettinia,∗, Rafaela Wagnera, Aleocídio Sette Balzanelob,
ndré  Luis de Souza Andrettab, Arthur Nascimento de Mourab, Catia Carolina Fabrisb,
duardo  Maranhão Gubertb
Hospital  Pequeno  Príncipe,  Curitiba,  PR,  Brazil
Pontifícia  Universidade  Católica  do  Paraná,  Curitiba,  PR,  Brazil
eceived  22  November  2015;  accepted  22  March  2016
vailable  online  24  April  2016
KEYWORDS
Prenatal  diagnosis;
Congenital
abnormalities;
CT  scan;
Doppler  ultrasound
Abstract
Objective:  To  report  a  patient  with  prenatal  diagnosis  of  portosystemic  shunt;  a  rare  condition
in humans.
Case  description: 17-Day-old  female  infant  admitted  for  investigation  of  suspected  diagno-
sis of  portosystemic  shunt,  presumed  in  obstetric  ultrasound.  The  hypothesis  was  conﬁrmed
after abdominal  angiography  and  liver  Doppler.  Other  tests  such  as  echocardiography  and
electroencephalogram  were  performed  to  investigate  possible  co-morbidities  or  associated
complications,  and  were  normal.  We  chose  conservative  shunt  treatment,  as  there  were  no
disease-related  complications  and  this  was  intrahepatic  shunt,  which  could  close  spontaneously
by the  age  of  2  years.
Comments:  Portosystemic  shunt  can  lead  to  various  complications  such  as  hepatic  encephalo-
pathy, hypergalactosemia,  liver  tumors,  and  hepatopulmonary  syndrome.  Most  diagnoses  are
done after  one  month  of  age,  after  such  complications  occur.  The  prenatal  diagnosis  of  this
patient provided  greater  security  for  the  clinical  picture  management,  as  well  as  regular  mon-
itoring, which  allows  the  anticipation  of  possible  complications  and  perform  interventional
procedures  when  needed.
© 2016  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
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Objetivo:  Descrever  a  história  clínica  de  paciente  com  diagnóstico  pré-natal  de  shunt  por-
tossistêmico,  condic¸ão  rara  na  espécie  humana.
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Descric¸ão  do  caso:  Recém-nascido  do  sexo  feminino  internada  aos  17  dias  para  investigac¸ão  de
suspeita diagnóstica  de  shunt  portossistêmico,  aventada  na  ecograﬁa  obstétrica.  A  hipótese  foi
conﬁrmada  após  angiotomograﬁa  do  abdome  e  ecodoppler  hepático.  Outros  exames,  como  eco-
cardiograma  e  eletroencefalograma,  foram  feitos  para  investigac¸ão  de  possíveis  comorbidades
ou complicac¸ões  associadas  e  tiveram  resultados  normais.  Optou-se  por  tratamento  conservador
do shunt,  já  que  não  havia  quaisquer  complicac¸ões  relacionadas  à  doenc¸a  e  tratava-se  de  shunt
intra-hepático,  que  pode  fechar  espontaneamente  até  os  dois  anos  de  idade.
Comentários:  O  shunt  portossistêmico  pode  levar  a  diversas  complicac¸ões,  como  encefalopatia
hepática, hipergalactosemia,  tumores  hepáticos  e  síndrome  hepatopulmonar.  A  maioria  dos
diagnósticos  é  feita  a  partir  de  um  mês  de  vida,  após  tais  complicac¸ões  ocorrerem.  O  diagnóstico
pré-natal dessa  paciente  possibilitou  maior  seguranc¸a para  o  manejo  do  quadro,  bem  como  um
acompanhamento  periódico  que  permite  antecipar  possíveis  complicac¸ões  e  adotar  conduta
intervencionista,  se  necessário.
©  2016  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY  (http://creativecommons.org/licenses/by/4.0/).
Figure  1  Abdominal  CT  angiography  --  venous  phase.  The
arrow points  to  dilation  of  the  intrahepatic  portal  vein,  with
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oIntroduction
Portosystemic  shunt  is  a  rare  condition,  which  was  ﬁrst
described  in  1793  by  John  Abernethy.  It  consists  of  congeni-
tal  vascular  anomaly  in  which  the  blood  from  the  portal  vein
drains  directly  into  a  systemic  vein,  deviating  from  the  liver
circulation.1,2
In  humans,  the  incidence  of  portosystemic  shunt  is  esti-
mated  at  one  per  30,000  births  and  is  associated  with  other
conditions,  such  as  gastrointestinal,  genitourinary,  cardio-
vascular,  and  bone  malformations.1--3
Case description
Newborn  baby  girl  transferred  to  the  service  with  17  days  of
life  for  investigation  of  possible  presence  of  portosystemic
shunt.  The  hypothetical  diagnosis  was  suggested  during  a
routine  obstetric  ultrasound  in  the  third  trimester  of  gesta-
tion  that,  besides  the  suspected  shunt,  showed  intrauterine
growth  restriction  (IUGR),  microcephaly,  shortening  of  the
long  bones,  and  increased  placental  size.  Mother  had  no
prior  or  during  pregnancy  comorbidities.
The  baby  was  born  at  37  weeks  of  gestational  age,  via
cesarean  section,  with  birth  weight  1900g,  small  for  the
gestational  age,4 and  Apgar  score  6  and  9  at  ﬁrst  and  5th
minutes,  respectively.  At  birth,  she  was  transferred  to  the
neonatal  intensive  care  unit  (NICU),  where  she  remained
for  11  days  to  gain  weight  and  get  treatment  for  other
complications,  such  as  respiratory  distress  and  neonatal
jaundice  requiring  phototherapy.  After  stabilization,  the
patient  was  transferred  to  the  Hospital  Pequeno  Principe,
in  order  to  investigate  the  suspected  diagnosis  of  portosys-
temic  shunt.
The  newborn  was  admitted  asymptomatic,  in  good  gen-
eral  condition,  ruddy,  hydrated,  and  vital  signs  within
normal  values.  Clinical  examination  showed  no  evidence
of  microcephaly  or  shortening  of  the  long  bones  observed
in  obstetric  ultrasound.  The  investigation  continued  with:
(1)  abdominal  ultrasound,  which  showed  no  change,  with
insufﬁcient  assessment  of  portal  vein;  (2)  computerized
tomography  (CT)  angiography,  which  indicated  liver  with
normal  dimensions,  contours,  and  density,  with  prominence
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tortosystemic  shunt.
f  the  left  portal  vein  branch,  up  to  the  periphery  of  the
eft  lateral  segment,  where  it  was  observed  vascular  dila-
ion  and  prominence  of  the  adjacent  left  hepatic  vein,  with
esemblance  of  intrahepatic  portosystemic  shunt  on  the  left
ateral  segment  of  the  liver  (Fig.  1);  (3)  Abdominal  ultra-
ound  with  Doppler,  which  showed  prominences  of  the  portal
ein  right  and  left  branches,  with  anomalous  path  of  right
ortal  vein,  with  posterior-superior  direction,  communica-
ion  signs  between  the  portal  vein  and  the  middle  hepatic
ein,  the  site  with  increased  peak  systolic  velocity  and
scillating  ﬂow,  suggestive  of  portosystemic  shunt  (Fig.  2).
ecause  of  the  association  of  the  shunt  with  other  dis-
ases  and  complications  other  tests  were  performed:  normal
lectroencephalogram,  normal  echocardiogram,  laboratory
ests  (Table  1).
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oigure  2  Abdominal  ultrasound  with  Doppler.  The  arrow  indi-
ates the  portosystemic  shunt.
After  diagnosis,  conservative  treatment  was  chosen  due
o  the  optimal  clinical  outcome,  absence  of  any  disease-
elated  complications,  and  type  of  shunt,  which  could  close
pontaneously.  The  child  remains  in  periodic  monitoring  with
linical  and  laboratory  assessments.
iscussion
ortosystemic  shunt  is  classiﬁed  into  intrahepatic  and  extra-
epatic.  Extrahepatic  shunt  directly  connects  the  portal  vein
runk  (or  one  of  its  branches)  with  the  vena  cava  (or  one  of  its
ranches).  In  intrahepatic  shunt  occurs  connection  between
Table  1  Laboratory  tests.
Tests  performed  Value  found  Reference  value
Albumin  3g/dL  2.8--4.4g/dL
Ammoniaa 55moL/L  9--33moL/L
Direct  bilirubin  0.48mg/dL  0.0--0.6mg/dL
Indirect  bilirubina 2.62mg/dL  0.2--1.0mg/dL
Total bilirubina 3.1mg/dL  0.6--1.4mg/dL
Ionized  calcium  1.41mmoL/L  1.15--1.32mmoL/L
Serum  creatinine  0.4mg/dL  0.1--0.5mg/dL
Alkaline  phosphatasea 385U/L  145--320U/L
Phosphorus  6.1mg/dL  3.9--6.5mg/dL
Gamma-glutamyl
transferasea
177U/L  Even  115U/L
Hemoglobin  12.8g/dL  9.0--18.0g/dL
White blood  cells  12,130L  5000--15,000uL
Magnesium  2mg/dL  1.7--2.3mg/dL
Platelets  320,000L  150,000--450,000L
Potassium  5.5mmoL/L  4.1--5.3mmoL/L
C-reactive  protein  6.3mg/dL  <10mg/L
Sodium  137.2mmoL/L  136--145mmoL/L
Prothrombin  activitya 67.9%  70--100%
APTT 39.9seg  (1.25)  0.8--1.25
AST 48U/L  20--60U/L
ALT 34U/L  6.0--45U/L
Urea 8mg/dL  5--40mg/dL
APTT, activated partial thromboplastin time; AST, aspartate
aminotransferase; ALT, alanine aminotransferase.
a Abnormal tests.
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he  portal  vein  (or  one  of  its  branches)  with  the  hepatic
ein  or  inferior  vena  cava.1,3,5,6 Thus,  the  intestinal  blood
asses  straight  into  the  systemic  circulation  without  passing
hrough  the  liver.7
Possible  factors  that  inﬂuence  the  development  of  this
ongenital  malformation  are:  (1)  genetic  component;  (2)
omplex  process  of  malformations,  with  the  shunt  associ-
ted  with  heart,  kidney,  bone,  and  other  malformations;  (3)
iver  hemangioma,  which  can  connect  the  vessels  of  portal
ystem  with  hepatic  vessels;  and  4)  absence  of  the  duc-
us  venosus  during  fetal  life,  which  leads  to  the  genesis  of
nomalous  vessels  to  fulﬁll  its  function.8
Most  portosystemic  shunt  diagnosis  occurs  after  one
onth  of  age  due  to  complications  or  even,  accidentally,
uring  the  investigation  of  associated  diseases,  such  as  heart
isease.2,8 In  about  10%  of  cases,  the  diagnosis  is  made  in  the
renatal  period,  as  occurred  in  the  patient  presented  here.8
renatal  identiﬁcation  of  shunt  has  become  more  frequent
ith  the  technical  improvement  of  diagnostic  imaging;  how-
ver,  this  method  has  limitations.9,10 Postnatal  ultrasound
s  important  and  useful  in  conﬁrming  changes  detected  in
renatal  testing.9
Because  part  of  the  mesenteric  circulation  is  deviated
rom  its  passage  through  the  liver,  the  metabolism  of
alactose,  ammonia,  and  other  toxic  compounds  fail  to
ccur  normally,  leading  to  increased  serum  concentrations
f  these  substances.2 The  prevailing  shunt  symptoms  are
ssociated  with  hepatic  encephalopathy  resulting  from  this
oxicity.6--8,11 Drowsiness,  confusion,  behavioral  changes,
rritability,  disorientation,  school  difﬁculties,  inattention
nd  hyperactivity  are  the  manifestations.  Mental  retar-
ation  and  seizures  may  also  be  identiﬁed.8,10 Hepatic
ncephalopathy  is  more  common  in  older  patients;  it  is  iden-
iﬁed  in  15%  of  cases  of  portosystemic  shunts  in  children.1
Other  serious  shunt  manifestations  are  hypergalac-
osemia,  neonatal  cholestasis,  liver  tumors,  pulmonary
rterial  hypertension,  hepatopulmonary  syndrome.6--8,11
t  may  also  be  associated  with:  membranoprolifera-
ive  glomerulonephritis,  hyperinsulinemia  with  hyper-  and
ypoglycemia,  hypothyroxinemia,  hyperandrogenism,  pan-
reatitis,  and  heart  failure.8,12 There  are  reports  in  the
iterature  suggesting  that  IUGR,  as  seen  in  our  patient,  may
lso  be  shunt-related.8,9,13 The  explanation  for  IUGR  is  the
eduction  of  liver  perfusion  caused  by  the  shunt.  Adequate
epatic  infusion  appears  to  induce  cell  proliferation  with
onsequent  increase  of  insulin-like  growth  factor-1  (IGF-1)
rom  mRNA  expression  in  the  liver,  as  well  as  increased
eripheral  cell  proliferation.  Given  the  above,  the  litera-
ure  suggests  that  in  cases  of  IUGR  without  obvious  etiology,
uch  as  placental  insufﬁciency  or  chromosomal  abnormali-
ies,  the  possible  diagnosis  of  portosystemic  shunt  should  be
onsidered  and  pre-  and  postnatal  ultrasound  performed.13
Eventually,  there  is  liver  atrophy  due  to  decreased  hep-
totrophic  substances  entering  the  liver  through  the  portal
irculation.1,2 Portal  hypertension  features,  such  as  ascites,
arices,  and  splenomegaly,  are  rare  in  congenital  portosys-
emic  shunt.  When  these  signs  are  present,  other  causes
f  spontaneous  shunt  should  be  considered.2 Laboratory
ests  may  show  increased  levels  of  transaminases,  gamma-
lutamyl  transferase,  prothrombin  activity,  ammonia,  and
ilirubin.  Serum  albumin  may  be  decreased.8 In  the  clinical
ase  described  here,  the  patient  presented  with  minimal
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increased  ammonia,  alkaline  phosphatase,  gamma-glutamyl
transferase  and  decreased  prothrombin  activity  without  any
clinical  consequences.  These  changes  were  not  considered
serious  shunt  complications.
The  imaging  test  of  choice  for  diagnosis  is  Doppler  ultra-
sound  of  the  portal  system.1,5,8 CT  scan  is  the  next  imaging
test  to  be  performed  to  better  detail  the  region  anatomy,
contributing  to  the  best  therapeutic  decision.8
Due  to  its  severe  potential  complications,  surgical  or
radiological  intervention  is  indicated  to  correct  the  por-
tosystemic  shunt.  Reports  in  the  literature  show  the  beneﬁt
of  this  repair  even  in  asymptomatic  shunts,  with  the  role
of  preventing  further  signiﬁcant  repercussions.6,8 Moreover,
the  older  the  child  and  the  larger  the  diameter  of  the  veins
involved  in  shunt,  the  harder  it  becomes  to  close  it,  empha-
sizing  the  importance  of  early  intervention.3 On  the  other
hand,  in  the  speciﬁc  situation  of  asymptomatic  intrahep-
atic  shunt  in  children  less  than  2  years  old,  watchful  waiting
is  indicated,  as  most  of  them  closes  spontaneously  before
24  months  of  age.  However,  if  it  does  not  close  until  the  age
of  2  years,  intervention  should  be  considered.6,8--10,13 Based
on  this  knowledge,  we  opted  for  watchful  waiting  until  our
patient  completed  2  years  of  age  or  until  the  appearance  of
signs  of  complications.
In  symptomatic  cases  requiring  therapeutic  interven-
tion,  there  are  reports  that,  after  the  shunt  resolution,
laboratory  abnormalities,  neurological  manifestations,
and  liver  tumors  regress  completely  or  at  least  improve
signiﬁcantly.8,10 Pulmonary  hypertension  can  be  resolved,
provided  that  the  shunt  is  corrected  before  the  devel-
opment  of  irreversible  vascular  lesions.8 There  is  also
improvement  of  cognitive  function  and  recovery  of  weight
and  height  in  the  presence  of  these  changes.10
Portosystemic  shunts  are  rare  diseases  with  potentially
serious  complications.  If  prenatal  diagnosis  has  not  been
made,  it  should  be  considered  in  the  postnatal  period
in  the  presence  of  encephalopathy,  pulmonary  hyperten-
sion,  hepatopulmonary  syndrome,  and  neonatal  cholestasis,
particularly  with  laboratory  abnormalities,  such  as  hyper-
ammonemia,  hypergalactosemia,  direct  hyperbilirubinemia,
and  increased  transaminases.  In  our  experience,  we  empha-
size  the  importance  of  prenatal  diagnosis,  which  allowed
greater  security  for  the  clinical  picture  management,  as  well
as  regular  monitoring,  which  allows  the  anticipation  of  pos-
sible  complications  and  perform  interventional  procedures
when  needed.Funding
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